Other Species / Isoforms
  EVL (mouse)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
Y16-p
ARASVMVyDDTSKKW
0 84
EVL (human) ARASVMVyDDTsKKW Y16-p
EVL iso2 (human) ARASVMVYDDTSKKW Y18
EVL (mouse) ARASVMVyDDTSKKW Y16-p
EVL (rat) ARASVMVYDDTSKKW Y16
S20
VMVyDDTSKKWVPIK
0 1
EVL (human) VMVyDDTsKKWVPIk S20-p
EVL iso2 (human) VMVYDDTSKKWVPIK S22
EVL (mouse) VMVyDDTSKKWVPIK S20
EVL (rat) VMVYDDTSKKWVPIK S20
K27
SKKWVPIKPGQQGFS
0 2
EVL (human) sKKWVPIkPGQQGFS K27-ub
EVL iso2 (human) SKKWVPIKPGQQGFS K29
EVL (mouse) SKKWVPIKPGQQGFS K27
EVL (rat) SKKWVPIKPGQQGFS K27
Y39-p
GFSRINIyHNTASST
0 10
EVL (human) GFSRINIyHNTASNT Y39-p
EVL iso2 (human) GFSRINIYHNTASNT Y41
EVL (mouse) GFSRINIyHNTASST Y39-p
EVL (rat) GFSRINIYHNTASNT Y39
S130
RQVQNGPSPEEMDIQ
0 5
EVL (human) RQVQNGPsPDEMDIQ S130-p
EVL iso2 (human) RQVQNGPSPDEMDIQ S132
EVL (mouse) RQVQNGPSPEEMDIQ S130
EVL (rat) RQVQNGPsPEEMDIQ S130-p
S150-p
EQQHRQEsLERRISA
0 4
EVL (human) HQQQRQEsLERRTsA S152-p
EVL iso2 (human) HQQQRQESLERRTSA S154
EVL (mouse) EQQHRQEsLERRISA S150-p
EVL (rat) EQQHRQEsLERRISA S150-p
S156
EsLERRISATGPILP
1 3
EVL (human) EsLERRTsATGPILP S158-p
EVL iso2 (human) ESLERRTSATGPILP S160
EVL (mouse) EsLERRISATGPILP S156
EVL (rat) EsLERRISATGPILP S156
S169
LPPGHPSSAASTTLS
0 1
EVL (human) LPPGHPSsAASAPVS S171-p
EVL iso2 (human) LPPGHPSSAASAPVS S173
EVL (mouse) LPPGHPSSAASTTLS S169
EVL (rat) LPPGHPSSAASATFS S169
S240-p
VQRPEDAsGGssPsG
0 3
EVL (human) VQRPEDAsGGSsPSG S242-p
EVL iso2 (human) VQRPEDASGGSSPSG S244
EVL (mouse) VQRPEDAsGGssPsG S240-p
EVL (rat) VQRPEDASGGSSPSG S240
S243-p
PEDAsGGssPsGTSK
0 2
EVL (human) PEDAsGGSsPSGtSk S245
EVL iso2 (human) PEDASGGSSPSGTSK S247
EVL (mouse) PEDAsGGssPsGTSK S243-p
EVL (rat) PEDASGGSSPSGTSK S243
S244-p
EDAsGGssPsGTSKS
Upstream
0 15
Treatment
  • insulin
EVL (human) EDAsGGSsPSGtSks S246-p
EVL iso2 (human) EDASGGSSPSGTSKS S248
EVL (mouse) EDAsGGssPsGTSKS S244-p
EVL (rat) EDASGGSSPSGTSKS S244
S246-p
AsGGssPsGTSKSDA
0 1
EVL (human) AsGGSsPSGtSksDA S248
EVL iso2 (human) ASGGSSPSGTSKSDA S250
EVL (mouse) AsGGssPsGTSKSDA S246-p
EVL (rat) ASGGSSPSGTSKSDA S246
T248
GGssPsGTSKSDANR
0 1
EVL (human) GGSsPSGtSksDANR T250-p
EVL iso2 (human) GGSSPSGTSKSDANR T252
EVL (mouse) GGssPsGTSKSDANR T248
EVL (rat) GGSSPSGTSKSDANR T248
K250
ssPsGTSKSDANRAs
0 1
EVL (human) SsPSGtSksDANRAs K252-ub
EVL iso2 (human) SSPSGTSKSDANRAS K254
EVL (mouse) ssPsGTSKSDANRAs K250
EVL (rat) SSPSGTSKSDANRAs K250
S251
sPsGTSKSDANRAss
0 1
EVL (human) sPSGtSksDANRAss S253-p
EVL iso2 (human) SPSGTSKSDANRASS S255
EVL (mouse) sPsGTSKSDANRAss S251
EVL (rat) SPSGTSKSDANRAsS S251
S257-p
KSDANRAssGGGGGG
Upstream
0 10
Treatment
  • LPS
EVL (human) ksDANRAssGGGGGG S259-p
EVL iso2 (human) KSDANRASSGGGGGG S261
EVL (mouse) KSDANRAssGGGGGG S257-p
EVL (rat) KSDANRAsSGGGGGG S257-p
S258-p
SDANRAssGGGGGGL
0 4
EVL (human) sDANRAssGGGGGGL S260-p
EVL iso2 (human) SDANRASSGGGGGGL S262
EVL (mouse) SDANRAssGGGGGGL S258-p
EVL (rat) SDANRAsSGGGGGGL S258
K278
KLLAKRRKAAsQTDK
0 1
EVL (human) KLLAKRRkAAsQSDK K280-ub
EVL iso2 (human) KLLAKRRKAASQSDK K282
EVL (mouse) KLLAKRRKAAsQTDK K278
EVL (rat) KLLAKRRKAASQTDK K278
S281-p
AKRRKAAsQTDKPAD
Upstream
0 4
Treatment
  • insulin
EVL (human) AKRRkAAsQSDKPAE S283-p
EVL iso2 (human) AKRRKAASQSDKPAE S285
EVL (mouse) AKRRKAAsQTDKPAD S281-p
EVL (rat) AKRRKAASQTDKPAD S281
S294
ADRKEDESQTEDPsT
0 1
EVL (human) AEKKEDEsQMEDPSt S296-p
EVL iso2 (human) AEKKEDESQMEDPST S298
EVL (mouse) ADRKEDESQTEDPsT S294
EVL (rat) ADRKEDENQTEDPST N294
S300-p
ESQTEDPsTsPsPGt
0 1
EVL (human) EsQMEDPStsPsPGT S302
EVL iso2 (human) ESQMEDPSTSPSPGT S304
EVL (mouse) ESQTEDPsTsPsPGt S300-p
EVL (rat) ENQTEDPSTsPSPGS S300
T301
SQTEDPsTsPsPGtR
0 1
EVL (human) sQMEDPStsPsPGTR T303-p
EVL iso2 (human) SQMEDPSTSPSPGTR T305
EVL (mouse) SQTEDPsTsPsPGtR T301
EVL (rat) NQTEDPSTsPSPGSR T301
S302-p
QTEDPsTsPsPGtRA
0 40
EVL (human) QMEDPStsPsPGTRA S304-p
EVL iso2 (human) QMEDPSTSPSPGTRA S306
EVL (mouse) QTEDPsTsPsPGtRA S302-p
EVL (rat) QTEDPSTsPSPGSRA S302-p
S304-p
EDPsTsPsPGtRATS
0 8
EVL (human) EDPStsPsPGTRAAs S306-p
EVL iso2 (human) EDPSTSPSPGTRAAS S308
EVL (mouse) EDPsTsPsPGtRATS S304-p
EVL (rat) EDPSTsPSPGSRATS S304
T307-p
sTsPsPGtRATSQPP
0 1
EVL (human) StsPsPGTRAAsQPP T309
EVL iso2 (human) STSPSPGTRAASQPP T311
EVL (mouse) sTsPsPGtRATSQPP T307-p
EVL (rat) STsPSPGSRATSQPP S307
S311
sPGtRATSQPPNSSE
0 2
EVL (human) sPGTRAAsQPPNSSE S313-p
EVL iso2 (human) SPGTRAASQPPNSSE S315
EVL (mouse) sPGtRATSQPPNSSE S311
EVL (rat) SPGSRATSQPPNSSE S311
S327-p
GRKPWERsNsVEKPV
Upstream
0 32
Treatment
  • long-term_potentiation
  • LPA
  • LPS
  • PTH(1-34)
EVL (human) GRKPWERsNsVEKPV S329-p
EVL iso2 (human) GRKPWERSNSVEKPV S331
EVL (mouse) GRKPWERsNsVEKPV S327-p
EVL (rat) GRKPWERsNsVEKPV S327-p
S329-p
KPWERsNsVEKPVSS
Upstream
0 111
Treatment
  • IL-33
  • long-term_potentiation
  • LPS
EVL (human) KPWERsNsVEKPVss S331-p
EVL iso2 (human) KPWERSNSVEKPVSS S333
EVL (mouse) KPWERsNsVEKPVSS S329-p
EVL (rat) KPWERsNsVEKPVSS S329-p
S335
NsVEKPVSSLLsRtP
0 6
EVL (human) NsVEKPVssILsRtP S337-p
EVL iso2 (human) NSVEKPVSSILSRTP S339
EVL (mouse) NsVEKPVSSLLsRtP S335
EVL (rat) NsVEKPVSSLLSRVK S335
S336
sVEKPVSSLLsRtPs
0 7
EVL (human) sVEKPVssILsRtPs S338-p
EVL iso2 (human) SVEKPVSSILSRTPS S340
EVL (mouse) sVEKPVSSLLsRtPs S336
EVL (rat) sVEKPVSSLLSRVKP S336
S339-p
KPVSSLLsRtPsVAK
0 22
EVL (human) KPVssILsRtPsVAK S341-p
EVL iso2 (human) KPVSSILSRTPSVAK S343
EVL (mouse) KPVSSLLsRtPsVAK S339-p
EVL (rat) KPVSSLLSRVKPAGs S339
T341-p
VSSLLsRtPsVAKsP
0 18
EVL (human) VssILsRtPsVAKsP T343-p
EVL iso2 (human) VSSILSRTPSVAKSP T345
EVL (mouse) VSSLLsRtPsVAKsP T341-p
EVL (rat) gap -
S343-p
SLLsRtPsVAKsPEA
Upstream
0 79
Treatment
  • LPS
EVL (human) sILsRtPsVAKsPEA S345-p
EVL iso2 (human) SILSRTPSVAKSPEA S347
EVL (mouse) SLLsRtPsVAKsPEA S343-p
EVL (rat) gap -
S347-p
RtPsVAKsPEAKsPL
Upstream
0 94
Treatment
  • IFN-gamma
  • LCMV_gp33-41_peptide
  • LPS
EVL (human) RtPsVAKsPEAKsPL S349-p
EVL iso2 (human) RTPSVAKSPEAKSPL S351
EVL (mouse) RtPsVAKsPEAKsPL S347-p
EVL (rat) gap -
S352-p
AKsPEAKsPLQSQPH
Upstream
0 38
Treatment
  • insulin
  • LPA
  • LPS
EVL (human) AKsPEAKsPLQsQPH S354-p
EVL iso2 (human) AKSPEAKSPLQSQPH S356
EVL (mouse) AKsPEAKsPLQSQPH S352-p
EVL (rat) gap -
S356
EAKsPLQSQPHSRVK
0 6
EVL (human) EAKsPLQsQPHsRMk S358-p
EVL iso2 (human) EAKSPLQSQPHSRMK S360
EVL (mouse) EAKsPLQSQPHSRVK S356
EVL (rat) gap -
S360
PLQSQPHSRVKPAGs
0 2
EVL (human) PLQsQPHsRMkPAGs S362-p
EVL iso2 (human) PLQSQPHSRMKPAGS S364
EVL (mouse) PLQSQPHSRVKPAGs S360
EVL (rat) gap -
K363
SQPHSRVKPAGsVND
0 1
EVL (human) sQPHsRMkPAGsVND K365-ub
EVL iso2 (human) SQPHSRMKPAGSVND K367
EVL (mouse) SQPHSRVKPAGsVND K363
EVL (rat) SSLLSRVKPAGsVND K342
S367-p
SRVKPAGsVNDVGLD
Upstream
0 34
Treatment
  • IFN-gamma
  • LPS
EVL (human) sRMkPAGsVNDMALD S369-p
EVL iso2 (human) SRMKPAGSVNDMALD S371
EVL (mouse) SRVKPAGsVNDVGLD S367-p
EVL (rat) SRVKPAGsVNDVGLD S346-p
K397
VRELHKVKEEIIDAI
0 1
EVL (human) VRELHKVKEEIIDAI K399
EVL iso2 (human) VRELHKVKEEIIDAI K401
EVL (mouse) VRELHKVKEEIIDAI K397
EVL (rat) VRELHKVkEEIIDAI K376-ac
K397
VRELHKVKEEIIDAI
0 1
EVL (human) VRELHKVkEEIIDAI K399-ub
EVL iso2 (human) VRELHKVKEEIIDAI K401
EVL (mouse) VRELHKVKEEIIDAI K397
EVL (rat) VRELHKVKEEIIDAI K376